CID 169501900

Sildenafil metabolite m8

Structural Information

Molecular Formula
C19H26N6O5S
SMILES
CCOC1=C(C=C(C=C1)S(=O)(=O)NCCN)C2=NC3=C(C(=O)N2)N(N=C3CC(C)O)C
InChI
InChI=1S/C19H26N6O5S/c1-4-30-15-6-5-12(31(28,29)21-8-7-20)10-13(15)18-22-16-14(9-11(2)26)24-25(3)17(16)19(27)23-18/h5-6,10-11,21,26H,4,7-9,20H2,1-3H3,(H,22,23,27)
InChIKey
HRBHANGXLRNHSE-UHFFFAOYSA-N
Compound name
N-(2-aminoethyl)-4-ethoxy-3-[3-(2-hydroxypropyl)-1-methyl-7-oxo-6H-pyrazolo[4,3-d]pyrimidin-5-yl]benzenesulfonamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

450.16855 Da
Monoisotopic Mass

-0.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 451.17583 205.8
[M+Na]+ 473.15777 214.4
[M-H]- 449.16127 206.9
[M+NH4]+ 468.20237 211.0
[M+K]+ 489.13171 208.2
[M+H-H2O]+ 433.16581 197.4
[M+HCOO]- 495.16675 217.2
[M+CH3COO]- 509.18240 231.5
[M+Na-2H]- 471.14322 206.8
[M]+ 450.16800 211.9
[M]- 450.16910 211.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.